Neptune Technologies and Bioressources

What Neptune Technologies and Bioressources does

Neptune Technologies and Bioressources is a Canada-based, privately held for-profit biotechnology company headquartered in Laval, Quebec, founded in 1998. Per its disclosed profile, the firm "researches, develops and commercializes proprietary bioactive ingredients," positioning it as a specialty ingredient supplier with proprietary upstream R&D and a B2B commercial model that serves downstream customers in nutraceutical, pharmaceutical, functional food, cosmetic, or animal-health end markets.

The company currently lists 51 to 100 employees, placing it in the small-to-mid tier of ingredient manufacturers — large enough to support research, formulation, regulatory, and commercial functions, but not large enough to suggest a vertically integrated finished-product or consumer-brand operation. Its technology surface is not disclosed in the available input — there are no APIs, no apps, no listed software integrations, no AI modalities, no patented technology claims, and no certifications captured in structured data. The corporate web presence is at neptunebiotech.com, consistent with a specialty-ingredient supplier rather than a digital platform or consumer marketplace. The pricing model, distribution channels, named customers, partnerships, certifications, and management team are all absent from the available source material, leaving the commercial mechanics of the business substantially opaque.

The materials also contain a large volume of unrelated content concerning "MIKATOTO," an Indonesian online-togel/gambling platform, which appears to be content noise rather than information about Neptune and has been disregarded in this analysis. As a result, all conclusions here rely only on the firmographic and structured-record blocks that actually pertain to Neptune Technologies and Bioressources; absent richer disclosure, the analytical conclusions (revenue band, growth trajectory, AI maturity) necessarily carry low confidence and explicit data-gap caveats.

Name

Neptune Technologies and Bioressources

Legal name

MIKATOTO

Website

https://neptunebiotech.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Neptune Technologies and Bioressources is a privately held Canadian biotechnology company, founded in 1998 and headquartered in Laval, Quebec, that researches, develops, and commercializes proprietary bioactive ingredients for downstream industry customers.

Ownership category

akta.pro rank

Headquarters

HQ city

Laval

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

Neptune Technologies and Bioressources researches, develops, and commercializes proprietary bioactive ingredients. The company applies biotechnological extraction and processing to transform biological resources into standardized bioactive compounds, which it then sells to industrial customers for use in health, nutrition, pharmaceutical, and related commercial applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Proprietary Bioactive Ingredients The company's overarching product line: proprietary bioactive ingredients researched, developed, and commercialized by Neptune for use by industrial customers in health, nutrition, pharmaceutical, and related applications. Targeted at B2B buyers formulating finished products.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Cargill: Global agribusiness and ingredient supplier operating a large health ingredients business (including omega-3 EPA/DHA from algae and fish), competing with Neptune across nutraceutical and functional-food supply.
• Royal DSM (dsm-firmenich): Global specialty ingredients giant with extensive omega-3, nutraceutical, and bioactive portfolios across human and animal nutrition; competes with Neptune for the same B2B ingredient customers at much larger scale.
• Kerry Group: Ireland-based taste and nutrition company that supplies functional ingredients, including bioactive and nutritional systems, to food, beverage, and supplement brands — overlapping with Neptune's ingredient customers.
• BASF: Largest chemical company with a significant nutrition and health ingredients division supplying bioactives, carotenoids, and omega-3s to dietary supplement and food manufacturers globally.
• Archer Daniels Midland (ADM): Global nutrition and bioactives supplier with a wide portfolio of plant- and marine-derived ingredients for human and animal nutrition; addresses the same downstream buyers as Neptune.

Emerging players

• Ingredients by Nature: US-based supplier of branded, science-backed nutraceutical ingredients (including citrus-derived bioactives) selling into dietary supplement brands — a comparable specialty ingredient commercializer to Neptune.
• Lallemand: Canadian-headquartered microbial and specialty ingredient company with a strong Canadian biotech footprint and a portfolio of nutritional bioactive ingredients — geographically and categorically adjacent to Neptune.
• Polaris: French marine biotech that develops and commercializes omega-3 and phospholipid ingredients from marine sources for nutraceutical applications, competing in a closely overlapping specialty bioactive niche.

Direct peers

• Aker BioMarine: Norwegian marine biotech company specializing in krill-derived bioactive ingredients (omega-3 phospholipids, astaxanthin) for nutraceutical and aquaculture markets — the closest direct competitor to Neptune's marine bioactive platform.

Regional players

• Waitaki Biosciences: New Zealand-based manufacturer of marine oil ingredients (including green-lipped mussel and omega-3 concentrates) supplying nutraceutical markets primarily outside North America — comparable marine bioactive model.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/Neptune_corp
• LinkedInlinkedin.com/company/neptunewellness

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neptune Technologies and Bioressources